ZEB1 and hepatocellular carcinoma: Taken together, these data revealed HMGB1 inhibitor glycyrrhizin suppressed HCC progression by decreasing ZEB1 and the combination of Rapamycin and glycyrrhizin was a more effective treatment than glycyrrhizin only.